תפריט כתבה
Eli Lilly takes aim at illicit market for its experimental weight-loss drug
CBS
13:00, עידכון: 13:11
The pharmaceutical company is filing lawsuits against six outlets selling versions of its promising but unapproved weight-loss drug, retatrutide.
